mRNA therapy revives p53 to combat ovarian tumors

Ovarian cancer is often very aggressive and responds poorly to the therapies currently available. A recent study by Goethe University Frankfurt and University Hospital Frankfurt offers hope that this could change in the medium term.

With a push from RFK Jr., baseless fears about flouride go mainstream

Adding fluoride to water is considered one of the great public health achievements of the 20th century. With President-elect Donald Trump in the White House,

November 13, 2024

The end of affirmative action means it’s time to revise pre-med requirements

Luz (not her real name) could be a great doctor. A Latina student from Arizona, she graduated at the top of her high school class

November 10, 2023

Net sales just below and earnings just above expectations – Forecast 2025 – Biotech Investments

Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/Forecast Drägerwerk AG & Co. KGaA: Preliminary figures 2024: Net sales just below and earnings just

January 16, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.